KELLY PATACA: Open Payments
NPI 1285235713 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 53 payments from 13 companies in 2025. Trend: 2023 $1,256 · 2024 $696 · 2025 $911
Food & beverage: $811Education: $100
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 17 | $225 |
| Exeltis, USA Inc. | 17 | $225 |
| Astellas Pharma US Inc | 2 | $125 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| Sage Therapeutics, LLC | 2 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Organon LLC | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Evofem Biosciences, Inc. | 3 | $28 |
Products named: SLYND, Qelbree, ZURZUVAE, ACCRUFER, MYFEMBREE, NEXPLANON, Kyleena, Phexxi.
Industry payments across CA — which companies pay providers there.
